Published in J Am Coll Cardiol on March 01, 1993
A hypothesis for vulnerable plaque rupture due to stress-induced debonding around cellular microcalcifications in thin fibrous caps. Proc Natl Acad Sci U S A (2006) 2.61
Necrotic core thickness and positive arterial remodeling index: emergent biomechanical factors for evaluating the risk of plaque rupture. Am J Physiol Heart Circ Physiol (2008) 1.58
Matrix vesicles in the fibrous cap of atherosclerotic plaque: possible contribution to plaque rupture. J Cell Mol Med (2008) 1.07
Effects of Geometric Variations on the Buckling of Arteries. Int J Appl Mech (2011) 0.99
Circumferential strain in the wall of the common carotid artery: comparing displacement-encoded and cine MRI in volunteers. Magn Reson Med (2008) 0.96
Estimation of nonlinear mechanical properties of vascular tissues via elastography. Cardiovasc Eng (2008) 0.93
Role of biomechanical forces in the natural history of coronary atherosclerosis. Nat Rev Cardiol (2016) 0.89
Intracoronary ultrasound: current state of the art. Br Heart J (1995) 0.88
Visualizing the stress distribution within vascular tissues using intravascular ultrasound elastography: a preliminary investigation. Ultrasound Med Biol (2015) 0.79
Intravascular ultrasound and optical coherence tomography imaging of coronary atherosclerosis. Int J Cardiovasc Imaging (2015) 0.79
Modeling of Mechanical Stress Exerted by Cholesterol Crystallization on Atherosclerotic Plaques. PLoS One (2016) 0.75
Imaging of coronary atherosclerosis and identification of the vulnerable plaque. Neth Heart J (2003) 0.75
Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol (1987) 5.33
Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol (1995) 5.26
Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest (2000) 4.79
Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker Selection in the Elderly Investigators. N Engl J Med (1998) 4.22
Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med (2001) 3.89
Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res (1987) 3.86
A mouse model of familial hypertrophic cardiomyopathy. Science (1996) 3.69
Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation (2001) 3.47
Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms. Circulation (1997) 3.38
Distribution of circumferential stress in ruptured and stable atherosclerotic lesions. A structural analysis with histopathological correlation. Circulation (1993) 3.29
Semaphorin III is needed for normal patterning and growth of nerves, bones and heart. Nature (1996) 2.94
Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation (1999) 2.73
An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy. J Clin Invest (2000) 2.56
The mechanics of running: how does stiffness couple with speed? J Biomech (1990) 2.54
Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. Am J Physiol (1999) 2.19
Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium. Proc Natl Acad Sci U S A (1997) 2.15
An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro. Circulation (2001) 2.09
Refinement of the alpha aminooleic acid bioprosthetic valve anticalcification technique. Ann Thorac Surg (1997) 2.05
Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy. Proc Natl Acad Sci U S A (1997) 2.02
Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice. J Clin Invest (1999) 2.02
Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. Biotechnol Bioeng (1999) 2.00
Aortic valve endothelial cells undergo transforming growth factor-beta-mediated and non-transforming growth factor-beta-mediated transdifferentiation in vitro. Am J Pathol (2001) 1.96
Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells. Am J Pathol (1991) 1.82
Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation (1987) 1.78
Functional living trileaflet heart valves grown in vitro. Circulation (2000) 1.77
Neuroprotection mediated by changes in the endothelial actin cytoskeleton. J Clin Invest (2000) 1.76
Circumferential stress and matrix metalloproteinase 1 in human coronary atherosclerosis. Implications for plaque rupture. Arterioscler Thromb Vasc Biol (1996) 1.71
Transient cardiac expression of constitutively active Galphaq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways. Proc Natl Acad Sci U S A (1998) 1.68
Induced expression of endothelial-leukocyte adhesion molecules in human cardiac allografts. Transplantation (1991) 1.62
Power spectrum analysis of heart rate variability in human cardiac transplant recipients. Circulation (1989) 1.60
Structure-dependent dynamic mechanical behavior of fibrous caps from human atherosclerotic plaques. Circulation (1991) 1.53
Surgical management of carcinoid heart disease. Ann Thorac Surg (1991) 1.50
Derivation and characterization of an efficiently myocarditic reovirus variant. J Virol (1989) 1.49
Pathology of explanted cryopreserved allograft heart valves: comparison with aortic valves from orthotopic heart transplants. J Thorac Cardiovasc Surg (1998) 1.45
Dilated cardiomyopathy in two transgenic mouse lines expressing activated G protein alpha(q): lack of correlation between phospholipase C activation and the phenotype. J Mol Cell Cardiol (2001) 1.43
Atrial natriuretic factor gene expression in ventricles of rats with spontaneous biventricular hypertrophy. J Clin Invest (1988) 1.42
Blood and albumin cardioplegia preserve endothelium-dependent microvascular responses. Ann Thorac Surg (1993) 1.41
Functions of vascular wall cells related to development of transplantation-associated coronary arteriosclerosis. Transplant Proc (1989) 1.40
Integrin-mediated collagen matrix reorganization by cultured human vascular smooth muscle cells. Circ Res (1995) 1.40
[Factorial and discriminant analyses of neuropsychological variables in familial and sporadic late onset Alzheimer disease]. Rev Neurol (2005) 1.39
Targeted ablation of the murine alpha-tropomyosin gene. Circ Res (1997) 1.38
Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am J Pathol (1983) 1.37
Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis. Am J Pathol (2001) 1.33
The mode selection trial (MOST) in sinus node dysfunction: design, rationale, and baseline characteristics of the first 1000 patients. Am Heart J (2000) 1.33
Toxicology and biocompatibility of bioglasses. J Biomed Mater Res (1981) 1.31
Comparison of two murine models of familial hypertrophic cardiomyopathy. Circ Res (2001) 1.30
Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the alpha cardiac myosin heavy chain gene. J Clin Invest (1999) 1.28
Noncollagenous bone matrix proteins, calcification, and thrombosis in carotid artery atherosclerosis. Arterioscler Thromb Vasc Biol (1999) 1.27
Effect of age on the development of cardiac hypertrophy produced by aortic constriction in the rat. Circ Res (1987) 1.27
Noninvasive assessment of endothelium-dependent flow-mediated dilation of the brachial artery. Vasc Med (1997) 1.26
Onset and progression of experimental bioprosthetic heart valve calcification. Lab Invest (1985) 1.24
Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. Circulation (1994) 1.22
Triphenyltetrazolium staining of irreversible ischemic injury following coronary artery occlusion in rats. Am J Pathol (1985) 1.22
Atherosclerotic aneurysms of aortocoronary vein grafts. Am J Cardiol (1988) 1.21
Natural history of focal moderate cardiac allograft rejection. Is treatment warranted? Circulation (1995) 1.16
Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation (2000) 1.16
Mechanisms of bioprosthetic heart valve failure: fatigue causes collagen denaturation and glycosaminoglycan loss. J Biomed Mater Res (1999) 1.15
Increased prevalence of significant tricuspid regurgitation in patients with transvenous pacemakers leads. Am J Cardiol (1998) 1.15
Al+++ binding studies and metallic cation effects on bioprosthetic heart valve calcification in the rat subdermal model. ASAIO Trans (1990) 1.13
Cardiac effects of noncardiac neoplasms. Cardiol Clin (1984) 1.12
Contribution of endothelial cells to calcium-dependent fluorescence transients in rabbit hearts loaded with indo 1. Circ Res (1990) 1.12
Effect of coronary reperfusion on myocardial hemorrhage and infarct healing. Am J Cardiol (1983) 1.11
Lipid lowering promotes accumulation of mature smooth muscle cells expressing smooth muscle myosin heavy chain isoforms in rabbit atheroma. Circ Res (1998) 1.09
AL preincubation inhibits calcification of bioprosthetic heart valve tissue in the rat subdermal model. ASAIO Trans (1989) 1.09
Responses of coronary arteries of cardiac transplant patients to acetylcholine. J Clin Invest (1988) 1.09
Calcification of bovine pericardium used in cardiac valve bioprostheses. Implications for the mechanisms of bioprosthetic tissue mineralization. Am J Pathol (1986) 1.09
Disseminated Candida glabrata: report of a uniquely severe infection and a literature review. Am J Clin Pathol (1983) 1.08
Dose-dependent effects of short-term methylprednisolone on myocardial infarct extent, scar formation, and ventricular function. Circulation (1983) 1.07
Tissue engineering of heart valves: in vitro experiences. Ann Thorac Surg (2000) 1.07
Expression of dihydropyridine receptor (Ca2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure. J Clin Invest (1992) 1.06
Diastolic dysfunction in hypertrophic cardiomyopathy. Effect on active force generation during systole. J Clin Invest (1991) 1.06
The role of glutaraldehyde-induced cross-links in calcification of bovine pericardium used in cardiac valve bioprostheses. Am J Pathol (1987) 1.06
Chromosomal variation and genome size support existence of cryptic species of Triatoma dimidiata with different epidemiological importance as Chagas disease vectors. Trop Med Int Health (2006) 1.06
Prediction of mechanical properties of human atherosclerotic tissue by high-frequency intravascular ultrasound imaging. An in vitro study. Arterioscler Thromb (1992) 1.06
Deciphering morphology in Triatominae: the evolutionary signals. Acta Trop (2008) 1.03
Elastin calcification and its prevention with aluminum chloride pretreatment. Am J Pathol (1999) 1.03
Imaging human atherosclerosis with 99mTc-labeled low density lipoproteins. Arteriosclerosis (1988) 1.02
Mechanical deformation promotes secretion of IL-1 alpha and IL-1 receptor antagonist. J Immunol (1997) 1.02
Endothelial communication. State of the art lecture. Hypertension (1988) 1.02
Scar thinning due to ibuprofen administration after experimental myocardial infarction. Am J Cardiol (1983) 1.01
Echocardiography-derived left ventricular end-systolic regional wall stress and matrix remodeling after experimental myocardial infarction. J Am Coll Cardiol (1999) 1.00
Aortic valve structure-function correlations: role of elastic fibers no longer a stretch of the imagination. J Heart Valve Dis (1997) 1.00
Inhibition of bioprosthetic heart valve calcification with aminodiphosphonate covalently bound to residual aldehyde groups. Ann Thorac Surg (1988) 0.99
Calcification of subcutaneously implanted type I collagen sponges. Effects of formaldehyde and glutaraldehyde pretreatments. Am J Pathol (1986) 0.99
Clinical features of hypertrophic cardiomyopathy caused by mutation of a "hot spot" in the alpha-tropomyosin gene. J Am Coll Cardiol (1997) 0.99
Physicochemical properties of calcific deposits isolated from porcine bioprosthetic heart valves removed from patients following 2-13 years function. J Biomed Mater Res (1994) 0.98
Inhibition of aortic wall calcification in bioprosthetic heart valves by ethanol pretreatment: biochemical and biophysical mechanisms. J Biomed Mater Res (1998) 0.98
Long-term failure rate and morphologic correlations in porcine bioprosthetic heart valves. Am J Cardiol (1983) 0.96
Severe hemolytic anemia following mitral valve repair. Am Heart J (1989) 0.96
Endothelial and smooth muscle cells express leukocyte adhesion molecules heterogeneously during acute rejection of rabbit cardiac allografts. Am J Pathol (1994) 0.96
Prevention of calcification of glutaraldehyde-crosslinked porcine aortic cusps by ethanol preincubation: mechanistic studies of protein structure and water-biomaterial relationships. J Biomed Mater Res (1998) 0.95
Benign intracardiac thyroid mass causing right ventricular outflow tract obstruction. Am J Cardiol (1985) 0.95
Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts. Circulation (1993) 0.95
Recovery and viability of an acute myocardial infarct after transmyocardial laser revascularization. J Am Coll Cardiol (1995) 0.94
Mechanism of efficacy of 2-amino oleic acid for inhibition of calcification of glutaraldehyde-pretreated porcine bioprosthetic heart valves. Circulation (1994) 0.94
Directions for improvement of substitute heart valves: National Heart, Lung, and Blood Institute's Working Group report on heart valves. J Biomed Mater Res (1997) 0.93
Effect of alpha naphthylthiourea on uptake of 5-hydroxytryptamine from the pulmonary circulation. Am Rev Respir Dis (1981) 0.93
Inhibition of calcification of bioprosthetic heart valves by local controlled-release diphosphonate. Science (1985) 0.93